
Results From ADVANCE-CIDP Trial Show IVIG 10% Effectively Treats CIDP Relapse
Findings from the ADVANCE-CIDP IVIG trial demonstrated that intravenous immunoglobulin (IVIG) 10% (Gammagard Liquid; Takeda) effectively treated relapses of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in adult patients.1 CIDP is a …